Carter Worth of Cornerstone Macro spoke on CNBC's "Fast Money," about stocks that could outperform in the second half of the year.
iShares NASDAQ Biotechnology Index (NASDAQ: IBB) has been trading sideways for the last three years and it is finally breaking out on the upside. He expects it to continue to move higher.
iShares Silver Trust (NYSE: SLV) could trade much higher, said Worth. He noticed a rounding bottom technical pattern on its charts and he wants to buy it.
Thermo Fisher Scientific Inc. (NYSE: TMO) and Danaher Corporation (NYSE: DHR) have outperformed both SPDR S&P 500 ETF Trust (NYSE: SPY) and PowerShares QQQ Trust (NASDAQ: QQQ) over a five-year period. They are not overdone because they have a lower beta than the market, explained Worth.
See more from Benzinga
- Cramer Shares His Thoughts On Sirius XM, Nokia And More
- Cramer Gives His Opinion On Lockheed Martin, Gap And More
- Carter Worth And Mike Khouw's TLT Trade
© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.